查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908491

生物樣本庫市場規模、佔有率和趨勢分析報告：按產品/服務、生物樣本類型、生物樣本庫類型、服務、應用、地區和細分市場預測（2026-2033 年）

Biobanks Market Size, Share & Trends Analysis Report By Product & Services (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物樣本庫市場概覽

全球生物樣本庫市場預計到 2025 年將價值 868.2 億美元，預計到 2033 年將達到 1,605.4 億美元。

預計從 2026 年到 2033 年，該行業將以 8.11% 的複合年成長率成長。對再生醫學、個人化醫療和癌症基因組研究等先進治療方法的研發投入巨大，是推動成長的關鍵因素。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 生物樣本庫市場變數、趨勢與範圍

  • 市場譜系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 生物樣本庫市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 生物樣本庫市場：產品/服務、估算與趨勢分析

  • 按產品/服務分類的市場佔有率（2025 年和 2033 年）
  • 產品
  • 市場規模、預測與趨勢分析（2021-2033）
    • 生物銀行設備
    • 生物銀行耗材
    • 實驗室資訊管理系統
  • 服務
  • 市場規模、預測與趨勢分析（2021-2033）
    • 生物銀行和儲存庫
    • 實驗室處理
    • 合格/驗證
    • 低溫運輸物流
    • 其他

第5章：生物樣本庫市場：依生物樣本類型分類的估算與趨勢分析

  • 按生物樣本類型分類的市場佔有率（2025 年和 2033 年）
  • 市場規模、預測與趨勢分析（2021-2033）
    • 人體組織
    • 人體器官
    • 幹細胞
    • 其他生物樣本

第6章 生物樣本庫市場：按生物樣本庫類型分類的估算和趨勢分析

  • 按生物樣本庫類型分類的市場佔有率（2025 年和 2033 年）
  • 市場規模、預測與趨勢分析（2021-2033）
    • 物理/物理生物樣本庫
    • 虛擬生物樣本庫

第7章 生物樣本庫市場：按應用分類的估算和趨勢分析

  • 按應用領域分類的市場佔有率（2025 年和 2033 年）
  • 市場規模、預測與趨勢分析（2021-2033）
    • 治療
    • 藥物發現與臨床研究
    • 臨床診斷
    • 其他

第8章 生物樣本庫市場：區域、估算和趨勢分析

  • 區域市場概覽
  • 區域市場佔有率分析（2025 年和 2033 年）
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2025年商業市場分析
  • 公司簡介/列表
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Qiagen
    • Hamilton Company
    • Tecan Trading AG
    • Danaher Corporation
    • Becton, Dickinson, and Company（BD）
    • Biocision, LLC.
    • Taylor-Wharton
    • Charles River Laboratories
    • Lonza
    • Stemcell Technologies
    • Biovault Family
    • Promocell Gmbh
    • Precision Cellular Storage Ltd.（Virgin Health Bank）
Product Code: GVR-2-68038-564-9

Biobanks Market Summary

The global biobanks market size was estimated at USD 86.82 billion in 2025 and is anticipated to reach USD 160.54 billion by 2033, growing at a CAGR of 8.11% from 2026 to 2033. High investments in the R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, are some of the driving factors.

Global Biobanks Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biobanks market report based on product & service, biospecimen type, biobank type, application, and region:

  • Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Product
    • Biobanking Equipment
    • Temperature Control Systems
    • Freezers & Refrigerators
    • Cryogenic Storage Systems
    • Thawing Equipment
    • Incubators & Centrifuges
    • Alarms & Monitoring Systems
    • Accessories & Other Equipment
    • Biobanking Consumables
    • Laboratory Information Management Systems
  • Services
    • Biobanking & Repository
    • Lab processing
    • Qualification/ Validation
    • Cold Chain Logistics
    • Other Services
  • Biospecimen Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Human Tissues
  • Human Organs
  • Stem Cells
    • Adult Stem Cells
    • Embryonic Stem Cells
    • IPS Cells
    • Other Stem Cells
  • Other Biospecimens
  • Biobank Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Physical/Real Biobanks
    • Tissue Biobanks
    • Population-Based Biobanks
    • Genetic (DNA/RNA)
    • Disease-Based Biobanks
  • Virtual Biobanks
  • Application Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Therapeutics
  • Drug Discovery & Clinical Research
  • Clinical Diagnostics
  • Other Applications
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Biospecimen Type
    • 1.2.3. Biobank Type
    • 1.2.4. Application
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biobanks Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increased focus on precision medicine and genetic testing
      • 3.2.1.2. Changes in biobanking operations
      • 3.2.1.3. Increase in the number of clinical trials globally
      • 3.2.1.4. Growing industry and research collaborations
      • 3.2.1.5. Technology advancement and automation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
      • 3.2.2.2. Sustainability challenges for biobanks
      • 3.2.2.3. Other challenges in biobanking specimens for research
  • 3.3. Biobanks Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Biobanks Market: Product & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Product & Services Market Share, 2025 & 2033
  • 4.3. Product
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 4.4.1. Biobanking Equipment
      • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.2. Temperature Control Systems
        • 4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.2.2. Freezers & Refrigerators
          • 4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.2.3. Cryogenic Storage Systems
        • 4.4.1.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.1.2.5. Thawing Equipment
        • 4.4.1.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.3. Incubators & Centrifuges
        • 4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.4. Alarms & Monitoring Systems
        • 4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.1.5. Accessories & Other Equipment
        • 4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Biobanking Consumables
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Laboratory Information Management Systems
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Services
  • 4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.6.1. Biobanking & repository
      • 4.6.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.2. Lab processing
      • 4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.3. Qualification/ Validation
      • 4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.4. Cold Chain Logistics
      • 4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.5. Other Services
      • 4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Biobanks Market: Biospecimen Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biospecimen Type Market Share, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 5.3.1. Human Tissues
      • 5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.2. Human Organs
      • 5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.3. Stem Cells
      • 5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.3.3.2. Adult Stem Cells
        • 5.3.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.3.3.3. Embryonic Stem Cells
        • 5.3.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.3.3.4. IPS Cells
        • 5.3.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 5.3.3.5. Other Stem Cells
        • 5.3.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.4. Other biospecimens
      • 5.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Biobanks Market: Biobank Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biobank Type Market Share, 2025 & 2033
  • 6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 6.3.1. Physical/Real biobanks
      • 6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 6.3.1.2. Tissue Biobanks
        • 6.3.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 6.3.1.3. Population-based biobanks
        • 6.3.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 6.3.1.4. Genetic (DNA/RNA)
        • 6.3.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 6.3.1.5. Disease-Based biobanks
        • 6.3.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.2. Virtual biobanks
      • 6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Biobanks Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Application Market Share, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 7.3.1. Therapeutics
      • 7.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.2. Drug discovery & clinical research
      • 7.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.3. Clinical Diagnostics
      • 7.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.4. Other Applications
      • 7.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Biobanks Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2025 & 2033
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Qiagen
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Hamilton Company
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Tecan Trading AG
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Danaher Corporation
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Becton, Dickinson, and Company (BD)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Biocision, LLC.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Taylor-Wharton
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Charles River Laboratories
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Lonza
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Stemcell Technologies
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Biovault Family
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Promocell Gmbh
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Precision Cellular Storage Ltd. (Virgin Health Bank)
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America biobanks market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 4 North America biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 5 North America biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 6 North America biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 7 U.S. biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 8 U.S. biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 9 U.S. biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 10 U.S. biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 11 Mexico biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 12 Mexico biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 13 Mexico biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 14 Mexico biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 16 Canada biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 17 Canada biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 18 Canada biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 19 Europe biobanks market, by region, 2021 - 2033 (USD Million)
  • Table 20 Europe biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 21 Europe biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 22 Europe biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 23 Europe biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 24 Germany biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 25 Germany biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 26 Germany biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 27 Germany biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 28 UK biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 29 UK biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 30 UK biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 31 UK biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 32 France biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 33 France biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 34 France biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 35 France biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 36 Italy biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 37 Italy biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 38 Italy biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 39 Italy biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 40 Spain biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 41 Spain biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 42 Spain biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 43 Spain biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 44 Denmark biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 45 Denmark biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 46 Denmark biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 47 Denmark biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 48 Sweden biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 49 Sweden biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 50 Sweden biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 51 Sweden biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 52 Norway biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 53 Norway biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 54 Norway biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 55 Norway biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific biobanks market, by region, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 61 China biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 62 China biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 63 China biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 64 China biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 65 Japan biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 66 Japan biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 67 Japan biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 68 Japan biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 69 India biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 70 India biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 71 India biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 72 India biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 73 South Korea biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 74 South Korea biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 75 South Korea biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 76 South Korea biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 77 Australia biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 78 Australia biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 79 Australia biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 80 Australia biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 81 Thailand biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 82 Thailand biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 83 Thailand biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 84 Thailand biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 85 Latin America biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 86 Latin America biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 87 Latin America biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 88 Latin America biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 89 Brazil biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 90 Brazil biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 91 Brazil biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 92 Brazil biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 93 Argentina biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 94 Argentina biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 95 Argentina biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 96 Argentina biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 97 MEA biobanks market, by region, 2021 - 2033 (USD Million)
  • Table 98 MEA biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 99 MEA biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 100 MEA biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 101 MEA biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 102 South Africa biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 103 South Africa biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 104 South Africa biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 105 South Africa biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 106 Saudi Arabia biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 110 UAE biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 111 UAE biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 112 UAE biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 113 UAE biobanks market, by application, 2021 - 2033 (USD Million)
  • Table 114 Kuwait biobanks market, by product & services, 2021 - 2033 (USD Million)
  • Table 115 Kuwait biobanks market, by biospecimen type, 2021 - 2033 (USD Million)
  • Table 116 Kuwait biobanks market, by biobank type, 2021 - 2033 (USD Million)
  • Table 117 Kuwait biobanks market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Biobanks market: market outlook
  • Fig. 9 Biobanks competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Biobanks market driver impact
  • Fig. 15 Biobanks market restraint impact
  • Fig. 16 Biobanks market strategic initiatives analysis
  • Fig. 17 Biobanks market: Product & services movement analysis
  • Fig. 18 Biobanks market: Product & services outlook and key takeaways
  • Fig. 19 Product market estimates and forecast, 2021 - 2033
  • Fig. 20 Biobanking equipment market estimates and forecast, 2021 - 2033
  • Fig. 21 Temperature control systems estimates and forecast, 2021 - 2033
  • Fig. 22 Freezers & refrigerators market estimates and forecast, 2021 - 2033
  • Fig. 23 Cryogenic storage systems market estimates and forecast, 2021 - 2033
  • Fig. 24 Thawing equipment market estimates and forecast, 2021 - 2033
  • Fig. 25 Incubators & centrifuges market estimates and forecast, 2021 - 2033
  • Fig. 26 Alarms & monitoring systems market estimates and forecast, 2021 - 2033
  • Fig. 27 Accessories & other equipment market estimates and forecast, 2021 - 2033
  • Fig. 28 Biobanking consumables market estimates and forecast, 2021 - 2033
  • Fig. 29 Laboratory information management systems market estimates and forecast, 2021 - 2033
  • Fig. 30 Services market estimates and forecasts, 2021 - 2033
  • Fig. 31 Biobanking & repository market estimates and forecasts, 2021 - 2033
  • Fig. 32 Lab processing market estimates and forecasts, 2021 - 2033
  • Fig. 33 Qualification/ Validation market estimates and forecasts, 2021 - 2033
  • Fig. 34 Cold chain logistics market estimates and forecasts, 2021 - 2033
  • Fig. 35 Other services market estimates and forecasts, 2021 - 2033
  • Fig. 36 Biobanks market: Biospecimen type movement analysis
  • Fig. 37 Biobanks market: Biospecimen type outlook and key takeaways
  • Fig. 38 Human tissues market estimates and forecasts, 2021 - 2033
  • Fig. 39 Human organs market estimates and forecasts, 2021 - 2033
  • Fig. 40 Stem cells market estimates and forecasts, 2021 - 2033
  • Fig. 41 Adult stem cells market estimates and forecasts, 2021 - 2033
  • Fig. 42 Embryonic stem cells market estimates and forecasts, 2021 - 2033
  • Fig. 43 IPS cells market estimates and forecasts, 2021 - 2033
  • Fig. 44 Other stem cells market estimates and forecasts, 2021 - 2033
  • Fig. 45 Other biospecimens market estimates and forecasts, 2021 - 2033
  • Fig. 46 Biobanks market: Biobank type movement analysis
  • Fig. 47 Biobanks market: Biobank type outlook and key takeaways
  • Fig. 48 Physical/Real biobanks market estimates and forecasts, 2021 - 2033
  • Fig. 49 Tissue biobanks market estimates and forecasts, 2021 - 2033
  • Fig. 50 Population-based biobanks market estimates and forecasts, 2021 - 2033
  • Fig. 51 Genetic (DNA/RNA) market estimates and forecasts, 2021 - 2033
  • Fig. 52 Disease-Based biobanks market estimates and forecasts, 2021 - 2033
  • Fig. 53 Virtual biobanks market estimates and forecasts, 2021 - 2033
  • Fig. 54 Biobanks market: Application movement analysis
  • Fig. 55 Biobanks market: Application outlook and key takeaways
  • Fig. 56 Therapeutics market estimates and forecasts, 2021 - 2033
  • Fig. 57 Drug discovery & clinical research market estimates and forecasts, 2021 - 2033
  • Fig. 58 Clinical diagnostics market estimates and forecasts, 2021 - 2033
  • Fig. 59 Other applications market estimates and forecasts, 2021 - 2033
  • Fig. 60 Global Biobanks market: Regional movement analysis
  • Fig. 61 Global Biobanks market: Regional outlook and key takeaways
  • Fig. 62 North America, by country
  • Fig. 63 North America
  • Fig. 64 North America market estimates and forecasts, 2021 - 2033
  • Fig. 65 U.S. country dynamics
  • Fig. 66 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 67 Canada country dynamics
  • Fig. 68 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 69 Mexico country dynamics
  • Fig. 70 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 71 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 72 UK country dynamics
  • Fig. 73 UK market estimates and forecasts, 2021 - 2033
  • Fig. 74 Germany country dynamics
  • Fig. 75 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 76 France country dynamics
  • Fig. 77 France market estimates and forecasts, 2021 - 2033
  • Fig. 78 Italy country dynamics
  • Fig. 79 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 80 Spain country dynamics
  • Fig. 81 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 82 Denmark country dynamics
  • Fig. 83 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 84 Sweden country dynamics
  • Fig. 85 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 86 Norway country dynamics
  • Fig. 87 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 88 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 89 China country dynamics
  • Fig. 90 China market estimates and forecasts, 2021 - 2033
  • Fig. 91 Japan country dynamics
  • Fig. 92 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 93 India country dynamics
  • Fig. 94 India market estimates and forecasts, 2021 - 2033
  • Fig. 95 Thailand country dynamics
  • Fig. 96 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 97 South Korea country dynamics
  • Fig. 98 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 99 Australia country dynamics
  • Fig. 100 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 101 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 102 Brazil country dynamics
  • Fig. 103 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 104 Argentina country dynamics
  • Fig. 105 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 106 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 107 South Africa country dynamics
  • Fig. 108 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 109 Saudi Arabia country dynamics
  • Fig. 110 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 111 UAE country dynamics
  • Fig. 112 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 113 Kuwait country dynamics
  • Fig. 114 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 115 Market position of key market players- Biobanks market